GB1125409A - Pharmaceutical compositions containing sulphoxides - Google Patents
Pharmaceutical compositions containing sulphoxidesInfo
- Publication number
- GB1125409A GB1125409A GB3380266A GB3380266A GB1125409A GB 1125409 A GB1125409 A GB 1125409A GB 3380266 A GB3380266 A GB 3380266A GB 3380266 A GB3380266 A GB 3380266A GB 1125409 A GB1125409 A GB 1125409A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulphoxides
- compositions
- penetrant
- aliphatic
- compositions containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 6
- 241000233866 Fungi Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 2
- -1 cyclic acetals Chemical class 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 2
- 239000006210 lotion Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- LYPJRFIBDHNQLY-UHFFFAOYSA-J 2-hydroxypropanoate;zirconium(4+) Chemical compound [Zr+4].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O LYPJRFIBDHNQLY-UHFFFAOYSA-J 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 239000004150 EU approved colour Substances 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000004378 air conditioning Methods 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 159000000013 aluminium salts Chemical class 0.000 abstract 1
- 229910000329 aluminium sulfate Inorganic materials 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001166 anti-perspirative effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000003213 antiperspirant Substances 0.000 abstract 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000004040 coloring Methods 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000007902 hard capsule Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003641 microbiacidal effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000003158 myorelaxant agent Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007901 soft capsule Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 239000004753 textile Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000080 wetting agent Substances 0.000 abstract 1
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
- C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47667665A | 1965-08-02 | 1965-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1125409A true GB1125409A (en) | 1968-08-28 |
Family
ID=23892803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3380266A Expired GB1125409A (en) | 1965-08-02 | 1966-07-27 | Pharmaceutical compositions containing sulphoxides |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE684960A (enrdf_load_stackoverflow) |
| FR (2) | FR5698M (enrdf_load_stackoverflow) |
| GB (1) | GB1125409A (enrdf_load_stackoverflow) |
| IL (1) | IL26210A (enrdf_load_stackoverflow) |
| NL (1) | NL6610878A (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888164A (en) * | 1985-12-27 | 1989-12-19 | L'oreal | Cosmetic composition for the treatment of oily skin and hair based on di(beta-hydroxyethyl) sulfoxide and the use thereof |
| EP1693052A1 (en) * | 2001-10-03 | 2006-08-23 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
| US9271931B2 (en) | 2001-10-03 | 2016-03-01 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
| US10058507B2 (en) | 2001-10-03 | 2018-08-28 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3984480A (en) * | 1970-05-12 | 1976-10-05 | L'oreal | Polyhydroxyl monosulfoxide surfactant |
-
1966
- 1966-07-25 IL IL2621066A patent/IL26210A/xx unknown
- 1966-07-27 GB GB3380266A patent/GB1125409A/en not_active Expired
- 1966-08-01 FR FR71681A patent/FR5698M/fr not_active Expired
- 1966-08-02 BE BE684960D patent/BE684960A/xx unknown
- 1966-08-02 NL NL6610878A patent/NL6610878A/xx unknown
- 1966-10-29 FR FR82108A patent/FR1505490A/fr not_active Expired
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888164A (en) * | 1985-12-27 | 1989-12-19 | L'oreal | Cosmetic composition for the treatment of oily skin and hair based on di(beta-hydroxyethyl) sulfoxide and the use thereof |
| EP1693052A1 (en) * | 2001-10-03 | 2006-08-23 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
| US9271931B2 (en) | 2001-10-03 | 2016-03-01 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
| US10058507B2 (en) | 2001-10-03 | 2018-08-28 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
| US10722464B2 (en) | 2001-10-03 | 2020-07-28 | Celator Pharmaceuticals, Inc. | Compositions for delivery of drug combinations |
Also Published As
| Publication number | Publication date |
|---|---|
| BE684960A (enrdf_load_stackoverflow) | 1967-02-02 |
| FR5698M (enrdf_load_stackoverflow) | 1968-02-19 |
| IL26210A (en) | 1970-12-24 |
| NL6610878A (enrdf_load_stackoverflow) | 1967-02-03 |
| FR1505490A (fr) | 1967-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4424232A (en) | Treatment of herpes simplex | |
| US4536404A (en) | Method and composition for treating post-herpetic neuralgia | |
| KR880000091A (ko) | 국소용 약제학적 조성물 이의 제조방법 및 이의 용도 | |
| ES8702784A1 (es) | Un procedimiento para preparar una composicion anticaspa a base de una sal de 1-hidroxi-2-piridintiona y una hidroxipiridona. | |
| NO843836L (no) | Terapeutisk aktive sulfamatderivater | |
| IT1210589B (it) | Procedimento per la preparazione dicomposti pirimidinici dotati di attivita' farmacologica particolarmente per il trattamento di infezioni batteriche loro intermedi prodotto ottenuto e composizioni farmaceutiche che li contengono | |
| NZ241494A (en) | Personal care formulation that contains an anti-microbial agent which is a thiohydroxamic acid derivative or a heterocyclic thione | |
| GB1125409A (en) | Pharmaceutical compositions containing sulphoxides | |
| GB1125410A (en) | Pharmaceutical compositions containing sulphones | |
| IT1193747B (it) | Composizioni e accorgimenti perfezionati per l'inibizione della formazione di composti esplosivi e dicondizioni di esplosivita' nei concentrati per argentatura per la deposizione chimica dell'argento senza passaggio di corrente | |
| IL107614A0 (en) | Vitamin d3 analogs their preparation and pharmaceutical compositions containing them | |
| NO822681L (no) | Vannfortynnbart preparat med baktericid og fungicid virkning | |
| JPS56115793A (en) | Phosphonohydroxyacetic acid* its salt* their manufacture and drug thereof as active component | |
| KR920700627A (ko) | 치료제로서 1-페닐-2-아미노에탄올 유도체의 신규한 용도 | |
| BE899634A (fr) | Composition cosmetique pour le traitement des cheveux et de la peau, contenant des oxathiazinones. | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| ATE24716T1 (de) | Lenkotrien-antagonisten. | |
| BE900186A (fr) | Compositions fongicides synergiques. | |
| SE8404560L (sv) | Saneringskomposition | |
| GB955766A (en) | New thioethers and process for their manufacture | |
| KR950703528A (ko) | 프로스타글란딘 e₁유연체 | |
| US3904765A (en) | Process for controlling lamellar dystrophy of fingernails | |
| JPS5634625A (en) | Antitumorigenic agent | |
| JPS6468304A (en) | Antiseptic agent | |
| ATE79618T1 (de) | Thiadiazolguanidine. |